Literature DB >> 2080868

Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza virus replication in vivo.

M Lüscher-Mattli1, R Glück.   

Abstract

The effect of dextran sulfate and related compounds on the fusion of influenza A virus with model membranes, composed of dioleylphosphatidyl-choline and cholesterol (1:0.5), was investigated by a fusion assay based on de-quenching of fluorescence of octadecyl-rhodamine-HC1 (R18). Dextran sulfate samples of molecular weight of 500,000, 8,000 and 5,000 were found to be potent inhibitors of the virus-liposome fusion process. Polygalacturonic acid also showed anti-fusion activity, but to a lesser extent. Uncharged dextran, positively charged diethylaminoethyldextran, and the monomer glucosamin-1,6-disulfate were ineffective. It was shown that dextran sulfate interacts with the virus. Our results suggest that dextran sulfate binds to and inactivates the viral fusion protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2080868     DOI: 10.1016/0166-3542(90)90064-e

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  10 in total

Review 1.  Future prospects in antiviral therapy.

Authors:  E H Wiltink
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

Review 2.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

3.  Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins.

Authors:  M Hosoya; J Balzarini; S Shigeta; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

4.  Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection.

Authors:  Werner E G Müller; Xiaohong Wang; Meik Neufurth; Heinz C Schröder
Journal:  Prog Mol Subcell Biol       Date:  2022

5.  In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion.

Authors:  S Ikeda; J Neyts; S Verma; A Wickramasinghe; P Mohan; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

6.  A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus.

Authors:  M Lüscher-Mattli; R Glück; C Kempf; M Zanoni-Grassi
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway.

Authors:  B W Banfield; Y Leduc; L Esford; K Schubert; F Tufaro
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 8.  The antiviral activities and mechanisms of marine polysaccharides: an overview.

Authors:  Wei Wang; Shi-Xin Wang; Hua-Shi Guan
Journal:  Mar Drugs       Date:  2012-12-12       Impact factor: 5.118

9.  Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity.

Authors:  Hiroshi Yamada; Satoshi Nagase; Kazuo Takahashi; Yoshihiro Sakoda; Hiroshi Kida; Shigefumi Okamoto
Journal:  Antiviral Res       Date:  2016-02-26       Impact factor: 5.970

Review 10.  Emerging antiviral strategies to interfere with influenza virus entry.

Authors:  Evelien Vanderlinden; Lieve Naesens
Journal:  Med Res Rev       Date:  2013-06-25       Impact factor: 12.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.